$4.1325
0.2025[5.15%]
Last update: 10:25AM Get Real Time Here
Aquestive Therapeutics
(NASDAQ:AQST)Latest News for Aquestive Therapeutics Stock (NASDAQ:AQST)
Aquestive Therapeutics Stock (NASDAQ: AQST)
Categories: All
Thursday, April 18, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
Friday, April 05, 2024
Thursday, April 04, 2024
- Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 4, 2024, 1:21PM
- Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On ThursdayAvi Kapoor - Apr 4, 2024, 10:44AM
- Aquestive Therapeutics shares are trading lower after the company filed for an up to $250 million mixed shelf offering.Benzinga Newsdesk - Apr 4, 2024, 7:36AM
Thursday, March 28, 2024
Wednesday, March 20, 2024
- Dow Surges 350 Points; Fed Holds Rates SteadyAvi Kapoor - Mar 20, 2024, 3:22PM
- Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Mar 20, 2024, 2:03PM
- Crude Oil Dips 2%; Signet Jewelers Shares Spike HigherAvi Kapoor - Mar 20, 2024, 12:47PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 20, 2024, 9:05AM
- Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 20, 2024, 8:20AM
- Aquestive Therapeutics shares are trading lower after the company announced the pricing of a $75 million underwritten public offering of 16,666,667 shares at $4.50 per share.Benzinga Newsdesk - Mar 20, 2024, 7:31AM
- Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionAvi Kapoor - Mar 20, 2024, 5:32AM
- Reported Earlier, Aquestive Therapeutics Prices $75M Underwritten Public Offering Of 16,666,667 Common Shares At $4.50/ShareBenzinga Newsdesk - Mar 20, 2024, 2:09AM
Tuesday, March 19, 2024
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Mar 19, 2024, 5:34PM
- Aquestive Therapeutics shares are trading lower after the company announced a proposed public offering.Benzinga Newsdesk - Mar 19, 2024, 4:04PM
- Aquestive Therapeutics Announces Proposed Public Offering Of Common Stock; Size Not DisclosedBenzinga Newsdesk - Mar 19, 2024, 4:02PM
Monday, March 18, 2024
Friday, March 15, 2024
- Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 15, 2024, 2:31PM
- Aquestive Therapeutics shares are trading higher after the company announced Anaphylm met all predefined primary and secondary pharmacokinetic endpoints.Benzinga Newsdesk - Mar 15, 2024, 12:17PM
- Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 15, 2024, 8:13AM
- JMP Securities Maintains Outperform on Aquestive Therapeutics, Raises Price Target to $10Benzinga Newsdesk - Mar 15, 2024, 6:59AM
Thursday, March 14, 2024
Monday, March 11, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
- Aquestive Therapeutics shares are trading higher after analysts at Wedbush and Lake Street raised their price targets on the stock.Benzinga Newsdesk - Mar 7, 2024, 3:33PM
- Wedbush Maintains Outperform on Aquestive Therapeutics, Raises Price Target to $9Benzinga Newsdesk - Mar 7, 2024, 12:30PM
- Lake Street Maintains Buy on Aquestive Therapeutics, Raises Price Target to $8Benzinga Newsdesk - Mar 7, 2024, 12:01PM
Tuesday, March 05, 2024
Monday, March 04, 2024
Thursday, February 15, 2024
Tuesday, December 05, 2023
Friday, November 10, 2023
Wednesday, November 08, 2023
Monday, November 06, 2023
Friday, November 03, 2023
Tuesday, October 10, 2023
Friday, September 22, 2023
Thursday, September 21, 2023
Wednesday, September 20, 2023
- Aquestive Therapeutics shares are trading higher after the company reaffirmed its timeline and pathway for Anaphylm Sublingual Film.Benzinga Newsdesk - Sep 20, 2023, 12:32PM
- Aquestive Therapeutics Reaffirms Timeline And Pathway For Anaphylm Sublingual Film; Trial To Commence In Q4 Following Following Alignment With The FDABenzinga Newsdesk - Sep 20, 2023, 9:06AM